Qualifications

Qualifications:

MBBS BSc MRCP FRCR MSc PGCert FHEA

Year qualified:

2002

Country of qualification:

UK

Registration & Memberships

Registration and licensing

  • GMC

Memberships and associations

  • Royal College of Radiologists
  • Higher Education Academy

Languages Spoken

  • English

Dr Sarah Needleman

Consultant Oncologist

MBBS BSc MRCP FRCR MSc PGCert FHEA

Dr Sarah Needleman qualified from University College London in 2002.  She completed her oncology training in some of the most respected cancer hospitals including UCLH, St Bartholomew’s, Royal Free and Mount Vernon. She has obtained an MSc in oncology and published oncological manuscripts related to breast and pelvic malignancy.

She is a consultant clinical oncologist specialising in radiotherapy for breast and urological malignancies. She is principal investigator for various breast cancer trials and is committed to delivering high quality, individualised patient care.

She is passionate about education and has been awarded two education fellowships, at UCL medical school and the Royal College of Radiologists (RCR). She has undertaken medical educational research and published related manuscripts. She has completed a Postgraduate Certification in Education and been awarded a Fellowship to Higher Education Academy.  She is the Royal College tutor at the Royal Free hospital.

She was selected for a Leadership fellowship programme, organized and presented at national education and leadership conferences. She has been an active member of the RCR and held various committee roles.

Specialities:

Oncology

Procedures offered:

Radiotherapy for Breast and Urological Malignancy

Published papers:

Radiation hazards in pregnancy and methods of prevention

Needleman SJ, Powell ME

Best Practice & Research Clinical Obstetrics & Gynaecology Oct

2015 

The use of complementary and alternative medicines (CAM) in brain tumour patients

Needleman SJ ,Wasim Z, Kassab S, Short SC

European Association for Neurooncology (EANO) Sept 2010

Hormone Receptor Positive Early Breast Cancer: What Role

for Aromatase Inhibitors?

Dewdney A, Needleman S

Clinical Medicine Reviews in Oncology 2010

Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.

Needleman SJ, Tobias JS.

Expert Rev Anticancer Ther. 2008 Dec;8(12): 1871-81.

Aromatase inhibitors in early hormone receptor-positive breast cancer : what is the optimal initiation time for the maximum benefit?

Needleman SJ, Tobias JS.

Drugs. 2008;68(1):1-15.

The validity of the Annual review of competence progression : a qualitative study of the perceptions of junior doctors and their trainers

Viney R, Rich A, Needleman S, Griffin A, Woolf K,

Journal of the Royal Society of Medicine 2017 Jan 1

You can’t be a person and a doctor”. The work-life balance of doctors in training: a national qualitative study

Rich A, Viney R, Needleman S, Griffin A, Woolf K

British Medical Journal Open Dec 2016

‘Causes of differential attainment in UK postgraduate medical training: a national qualitative study

Woolf K, Rich A, Viney R, Needleman S, Griffin A

British Medical Journal Open Nov 2016 

Fair Training Pathways for All: Understanding Experiences of Progression’

Woolf K, Rich A, Viney R, Rigby M, Needleman S, Griffin A

General Medical Council report Jul 2016

Using role models to inspire the next generation of female leaders

Needleman S, Gafson I

UCL Partners Education Conference 2016 Educational innovation through partnership Nov 2016

What women perceive makes a ‘good leader’

Needleman S, Gafson I

International Medical Women’s Federation (MWF) Autumn Conference 2016 Winner of the Elizabeth Garrett Anderson prize Nov 2016

The PAL Project : Peer Assisted Learning in Medicine UCL

Howman M, Bertfield D, Needleman S

www.ucl.ac.uk/acme/The%20PAL%20Project.doc 2002

Dr Sarah Needleman, consultant Oncologist is available to be seen for consultations at the Royal Free Private Patients Unit Hampstead.